Research indicates that rhinosinusitis affects 5-12% of the global population, and among those with chronic rhinosinusitis, 25-30% also have nasal polyps. Often, rhinosinusitis is accompanied by nasal polyps—benign growths that can obstruct airflow—and asthma often worsens in patients with rhinosinusitis and nasal polyps due to shared inflammatory pathways. Join us as we delve into the […]
Deepen your understanding of pharmacological treatment as a cornerstone of effective tobacco treatment. This session explores the neurobiological basis of nicotine dependence and provides a comprehensive review of current clinical guidelines for pharmacotherapy. Participants will address common barriers to effective medication prescribing and use, enhancing their confidence to help patients successfully quit tobacco with evidence-based […]
Strengthen your ability to engage and support patients through Motivational Interviewing (MI), a powerful, evidence-based approach to supporting tobacco cessation. Participants will gain an understanding of the core principles and processes that define effective MI, including how to incorporate the OAR (Open-ended questions, Affirmations, Reflections) framework into clinical interactions. The session will also introduce practical […]
INHALE prepares regular PO and Clinical level newsletters that contain:
Arbor Lakes Building 3, Floor 3
4251 Plymouth Rd.
Ann Arbor, MI 48105
Support for the INHALE CQI is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs.
Although Blue Cross Blue Shield of Michigan and the INHALE CQI work in partnership, the opinions, beliefs, and viewpoints expressed by INHALE CQI do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.
